These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33416886)

  • 1. Assessment of Mortality Among Durable Left Ventricular Assist Device Recipients Ineligible for Clinical Trials.
    Brescia AA; Watt TMF; Pagani FD; Cascino TM; Zhang M; McCullough JS; Shore S; Likosky DS; Aaronson KD; Thompson MP;
    JAMA Netw Open; 2021 Jan; 4(1):e2032865. PubMed ID: 33416886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalizability of Trial Data to Real-World Practice: An Analysis of The Society of Thoracic Surgeons Intermacs Database.
    Brescia AA; Watt TMF; Pagani FD; Cascino TM; Zhang M; McCullough JS; Shore S; Likosky DS; Aaronson KD; Cantor RS; Deng L; Kirklin JK; Thompson MP
    Ann Thorac Surg; 2022 Oct; 114(4):1307-1317. PubMed ID: 34619136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
    Mezzacappa C; Ravindra NG; Caraballo C; Chouairi F; Miller PE; Clarke JD; Gruen J; Mori M; McCullough M; Mullan C; Geirsson A; Rogers JG; Anwer M; Desai N; Ahmad T
    PLoS One; 2020; 15(12):e0242928. PubMed ID: 33270648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
    Kilic A; Seese L; Pagani F; Kormos R
    J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of MOMENTUM 3 Trial Eligibility on Left Ventricular Assist Device Outcomes: A Real-World Experience.
    George TJ; Kabra N; DiMaio JM; Rawitscher DA; Afzal A
    J Surg Res; 2023 Jul; 287():40-46. PubMed ID: 36868122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter evaluation of the HeartMate 3 risk score.
    Grewal J; Tripathi N; Bortner B; Gregoski MJ; Cook D; Britt A; Hajj J; Rofael M; Sheidu M; Montovano MJ; Mehta M; Hajduczok AG; Rajapreyar IN; Brailovsky Y; Genuardi MV; Kanwar MK; Atluri P; Lander M; Shah P; Hsu S; Kilic A; Houston BA; Mehra MR; Sheikh FH; Tedford RJ
    J Heart Lung Transplant; 2024 Apr; 43(4):626-632. PubMed ID: 38061468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events.
    Bruce CR; Minard CG; Wilhelms LA; Abraham M; Amione-Guerra J; Pham L; Grogan SD; Trachtenberg B; Smith ML; Bruckner BA; Estep JD; Kostick KM
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28073849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis.
    Caraballo C; DeFilippis EM; Nakagawa S; Ravindra NG; Miller PE; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Mullan C; Ali A; Maurer MS; Desai NR; Ahmad T; Topkara VK
    JACC Heart Fail; 2019 Dec; 7(12):1069-1078. PubMed ID: 31779930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation: An INTERMACS Analysis.
    Cowger JA; Stulak JM; Shah P; Dardas TF; Pagani FD; Dunlay SM; Maltais S; Aaronson KD; Singh R; Mokadam NA; Kirklin JK; Salerno CT
    JACC Heart Fail; 2017 Oct; 5(10):691-699. PubMed ID: 28888521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.
    Karason K; Lund LH; Dalén M; Björklund E; Grinnemo K; Braun O; Nilsson J; van der Wal H; Holm J; Hübbert L; Lindmark K; Szabo B; Holmberg E; Dellgren G;
    Eur J Heart Fail; 2020 Apr; 22(4):739-750. PubMed ID: 32100946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study.
    Pagani FD; Mehra MR; Cowger JA; Horstmanshof DA; Silvestry SC; Atluri P; Cleveland JC; Lindenfeld J; Roberts GJ; Bharmi R; Dalal N; Kormos RL; Rogers JG
    J Heart Lung Transplant; 2021 May; 40(5):323-333. PubMed ID: 33744086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.